Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.6 USD | -4.48% |
|
-5.88% | +4.58% |
Jun. 21 | Sector Update: Health Care Stocks Gain in Late Afternoon | MT |
Jun. 21 | Lexicon Pharmaceuticals Resubmits New Drug Application for Potential Type 1 Diabetes Therapy | MT |
Financials (USD)
Sales 2024 * | 27.96M | Sales 2025 * | 98.48M | Capitalization | 578M |
---|---|---|---|---|---|
Net income 2024 * | -194M | Net income 2025 * | -176M | EV / Sales 2024 * | 20.7 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 5.87 x |
P/E ratio 2024 * |
-2.15
x | P/E ratio 2025 * |
-2.64
x | Employees | 285 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.44% |
Latest transcript on Lexicon Pharmaceuticals, Inc.
1 day | -4.48% | ||
1 week | -5.88% | ||
Current month | -4.76% | ||
1 month | -5.88% | ||
3 months | -27.60% | ||
6 months | +0.63% | ||
Current year | +4.58% |
![Extreme 1.6](/images/extremecours_fleche.png)
![Extreme 1.6](/images/extremecours_fleche.png)
![Extreme 1.24](/images/extremecours_fleche.png)
![Extreme 0.92](/images/extremecours_fleche.png)
![Extreme 0.92](/images/extremecours_fleche.png)
![Extreme 0.92](/images/extremecours_fleche.png)
![Extreme 0.92](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Lonnel Coats
CEO | Chief Executive Officer | 58 | 14-07-06 |
Jeffrey Wade
DFI | Director of Finance/CFO | 59 | 98-12-31 |
Craig Granowitz
CTO | Chief Tech/Sci/R&D Officer | 60 | 21-08-01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Lefkowitz
BRD | Director/Board Member | 80 | 01-01-31 |
Ray Debbane
CHM | Chairman | 69 | 07-07-31 |
Director/Board Member | 65 | 07-08-27 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 9 M€ | +11.07% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-07-02 | 1.6 | -4.48% | 1,764,941 |
24-07-01 | 1.675 | -0.30% | 1,616,733 |
24-06-28 | 1.68 | -3.45% | 4,749,863 |
24-06-27 | 1.74 | +3.57% | 1,831,441 |
24-06-26 | 1.68 | -1.18% | 2,103,646 |
Delayed Quote Nasdaq, July 02, 2024 at 04:00 pm EDT
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.58% | 578M | |
+16.44% | 122B | |
+18.94% | 113B | |
+18.49% | 26.22B | |
-25.37% | 19.01B | |
-19.77% | 15.71B | |
-20.20% | 15.22B | |
-47.37% | 14.72B | |
+59.91% | 14.58B | |
+4.35% | 13.84B |
- Stock Market
- Equities
- LXRX Stock